Dual-mode imaging In 2023, SpectraWAVE received US Food & Drug Administration (FDA) pre-market approval for its “HyperVue” ...
Philips has agreed to acquire SpectraWAVE, a firm making tools to help diagnose and guide treatment of coronary artery ...
Amsterdam, the Netherlands Tuesday, December 16, 2025, 17:00 Hrs [IST] ...
Philips acquires SpectraWave as medtech deals increase in December, with AI-powered coronary imaging technology boosting portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback